Current filters:

Rest of the WorldDiabetes

Case study draws attention to innovator brand preferences in Kenya


Some of the stronger performing brands in Kenya’s pharmaceutical market have been highlighted in a…

Antibiotics and Infectious diseasesCardio-vascularDiabetesGlaxoSmithKlineMarkets & MarketingPharmaceuticalRest of the World

Sanofi strengthens its presence in Algeria with €70 million investment

Sanofi strengthens its presence in Algeria with €70 million investment


French drug major Sanofi revealed today that construction has begun on its new Sidi Abdellah industrial…

Cardio-vascularDiabetesFinancialPharmaceuticalProductionRest of the WorldSanofi

Hikma in-licenses inhaled insulin for MENA; Advaxis and FusionVax Asia deal


Jordan-based Hikma Pharmaceuticals (LSE: HIK) has signed a licensing and distribution agreement with…

AdvaxisADXS-HPVAsia-PacificDance 01Dance BiopharmDiabetesFusionVaxHikma PharmaceuticalsImmunologicalsLicensingOncologyPharmaceuticalRest of the World

Merck Serono collaborates with Neopharma for production in UAE


Merck Serono, a division of Germany's Merck KGaA (MRK: DE), Germany, and Unite Arab Emirates drug manufacturer…

DiabetesEuthyroxGlucophageGlucophage XRMerck KGaAMerck SeronoNeopharmaPharmaceuticalProductionRest of the WorldWomen's Health

Novo Nordisk tests a new business model to improve insulin access in Kenya


As part of an official Danish state visit to Kenya, global insulin giant Novo Nordisk (NOV: N) last week…

DiabetesInsulinMarkets & MarketingNovo NordiskPharmaceuticalPricingRest of the World

Fero expands diabetes treatment Sucanon presence in the Middle East


Canada-based Fero Industries (OTCQB: FROI), the exclusive owner, producer and distributor of the type…

DiabetesFero IndustriesLicensingPharmaceuticalPremium PharmaRest of the WorldSucanon

Denmark’s Novo Nordisk partners to tackle Qatar’s diabetes problem


According to Danish insulin giant Novo Nordisk (NVO: N) diabetes is on the rise in Qatar and poses a…

DiabetesHealthcareNovo NordiskPharmaceuticalRest of the World

Alarming lack of diabetes awareness across the Middle East and Northern Africa regions identified in new survey


With the incidence of diabetes escalating across the Middle East and Northern Africa (MENA) region, new…

DiabetesMarkets & MarketingNovo NordiskPharmaceuticalRest of the World

Back to top